David Turkaly
Stock Analyst at JMP Securities
(2.23)
# 2,694
Out of 4,906 analysts
137
Total ratings
40.31%
Success rate
-3.49%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $10.67 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $51.89 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $73.77 | +35.56% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $222.65 | +25.76% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $11.36 | +120.07% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $26.30 | +109.13% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $92.59 | +35.00% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $481.58 | +3.82% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $387.32 | - | 3 | May 5, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $109.79 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.98 | +253.54% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $50 | $22.04 | +126.86% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $11.61 | +123.94% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $16.65 | +92.19% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $9.88 | +61.94% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $71.56 | +56.51% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.22 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.88 | -22.68% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.16 | -45.41% | 1 | Oct 6, 2017 |
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.67
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $51.89
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $73.77
Upside: +35.56%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $222.65
Upside: +25.76%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $11.36
Upside: +120.07%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $26.30
Upside: +109.13%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $92.59
Upside: +35.00%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $481.58
Upside: +3.82%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $387.32
Upside: -
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $109.79
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.98
Upside: +253.54%
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $22.04
Upside: +126.86%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $11.61
Upside: +123.94%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $16.65
Upside: +92.19%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $9.88
Upside: +61.94%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $71.56
Upside: +56.51%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.22
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.88
Upside: -22.68%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.16
Upside: -45.41%